Med-IQ

Course Listings: Dermatology

All Results (4)
Format: Live Events (0) Online Activities (4)

Viewpoints on Atopic Dermatitis: How Emerging Treatments May Change the Management of Moderate-to-Severe Disease

View Course

Format: E-Publication

    Maximum Credits:
  • 0.5 AMA PRA Category 1 Credit(s)

Course Description: This interactive CME publication reviews current clinical evidence on the use of novel agents targeting cytokine signaling for the systemic treatment of moderate-to-severe atopic dermatitis (AD). Survey responses from community allergists and dermatologists regarding these agents are integrated with expert insights on key survey findings.


Targeting IL-6 Signaling in the Treatment of Rheumatoid Arthritis

View Course

Format: E-Publication

    Maximum Credits:
  • 0.5 AMA PRA Category 1 Credit(s)

Course Description: This digital CME publication is based on a Q&A session between Elena M. Massarotti, MD, and William F.C. Rigby, MD, that explored the potential role and benefits of targeting the interleukin 6 (IL-6) pathway to treat moderate-to-severe rheumatoid arthritis (RA). Faculty discuss how IL-6 is involved in the pathophysiology of RA and provide insight on…More


Case Simulations in Metastatic Melanoma: Navigating Complex Treatment Decisions

View Course

Format: Simulation

    Maximum Credits:
  • 1.0 AMA PRA Category 1 Credit(s)

Course Description: In these video-enhanced, CME-certified, case-based simulations, clinicians are challenged to select first- and subsequent-line treatment regimens for two fictional patients with stage IV melanoma. Throughout the activity, clinicians must consider patient- and tumor-related characteristics, patient preferences, and contemporary evidence to make appropriate…More


The Evolving Therapeutic Landscape for Moderate-to-Severe Atopic Dermatitis

View Course

Format: Med-IQ Express

    Maximum Credits:
  • 0.25 AMA PRA Category 1 Credit(s)

Course Description: This CME-certified activity focuses on breakthrough therapy in clinical development for the treatment of patients with moderate-to-severe atopic dermatitis. It begins with a brief video in which an expert dermatologist offers clinical commentary; the clinical science regarding the use of targeted agents that inhibit cytokines involved in T helper 2 polarization…More